FDA OK's 1-Day Initiation for Long-Acting Injectable Schizophrenia Tx - MedPage Today

MedPage TodayFDA OK's 1-Day Initiation for Long-Acting Injectable Schizophrenia TxMedPage TodayIn one of the phase I studies presented earlier this year at the American Psychiatric Association annual meeting, the 1-day treatment was able to achieve therapeutic levels comparable to the 21-day initiation regimen, assessed in combination with 441 ...FDA Approves Aristada Initio for Same-Day Schizophrenia TreatmentMD Magazineall 15 news articles »